87% Complete Remission Rate With Nilotinib in ALL87% Complete Remission Rate With Nilotinib in ALL
Low-intensity chemotherapy plus nilotinib was highly effective in older patients, and might be an alternative to stem cell transplantation. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Chemotherapy | Hematology | Nilotinib | Stem Cell Therapy | Stem Cells | Tasigna | Transplants